July 10 (Reuters) -
FDA EMBRACES RADICAL TRANSPARENCY BY PUBLISHING COMPLETE RESPONSE LETTERS
US FDA: PUBLISHED MORE THAN 200 DECISION LETTERS, KNOWN AS COMPLETE RESPONSE LETTERS
US FDA: IN PROCESS OF PUBLISHING ADDITIONAL CRLS FROM ITS ARCHIVES
Source text: [ID:]
Further company coverage: [ ]